The ROE as of September 2024 (TTM) for Equillium, Inc. (EQ) is -36.88%

According to Equillium, Inc.’s latest financial reports and current stock price. The company's current ROE is -36.88%. This represents a change of 302.67% compared to the average of -9.16% of the last 4 quarters.

Equillium, Inc. (EQ) Historical ROE (quarterly & annually)

How has EQ ROE performed in the past?

The mean historical ROE of Equillium, Inc. over the last ten years is -68.37%. The current -36.88% ROE has changed -46.05% with respect to the historical average. Over the past ten years (40 quarters), EQ's ROE was at its highest in in the September 2018 quarter at 47.37%. The ROE was at its lowest in in the March 2022 quarter at -114.89%.

Equillium, Inc. (EQ) ROE by Quarter and Year

Discovering the peaks and valleys of Equillium, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Equillium, Inc. (EQ) Average ROE

How has EQ ROE performed in the past?

The current ROE of Equillium, Inc. (EQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Equillium, Inc. (EQ) ROE vs. Peers

How is EQ’s ROE compared to its peers?

Equillium, Inc.’s ROE is greater than Lyra Therapeutics, Inc. (-143.74%), greater than HOOKIPA Pharma Inc. (-51.77%), greater than LianBio (-38.06%), greater than Jasper Therapeutics, Inc. (-64.68%), less than Cingulate Inc. (11.47%), greater than SAB Biotherapeutics, Inc. (-94.04%), greater than Anebulo Pharmaceuticals, Inc. (-122.97%), greater than Cadrenal Therapeutics, Inc. Common Stock (-93.71%), greater than Monopar Therapeutics Inc. (-110.60%), less than Spero Therapeutics, Inc. (20.70%), greater than Bolt Biotherapeutics, Inc. (-61.40%), less than Coherus BioSciences, Inc. (23.81%), greater than Gracell Biotechnologies Inc. (-37.20%), greater than Neoleukin Therapeutics, Inc. (-47.64%), greater than Ikena Oncology, Inc. (-42.81%), greater than Werewolf Therapeutics, Inc. (-48.25%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than Quoin Pharmaceuticals, Ltd. (-112.11%), greater than Pasithea Therapeutics Corp. (-74.63%), greater than aTyr Pharma, Inc. (-56.83%), greater than Trevi Therapeutics, Inc. (-49.92%), greater than Cue Biopharma, Inc. (-142.93%), greater than AN2 Therapeutics, Inc. (-54.72%), greater than BioAtla, Inc. (-169.69%),

Build a custom stock screener for Equillium, Inc. (EQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Equillium, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Equillium, Inc. (EQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Equillium, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.